Intradermic injection vs. oral treatment of tinnitus

Therapie

Volumn , Issue 4, 2001, Pages 403-407

  Savastano, M ^a   Tomaselli, F ^b   Maggiori, S ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b International Fatebenefratelli Foundation   (Italy)

Author keywords

Intradermic injection.; Tinnitus; Vasoactive therapy

Indexed keywords

CLORICROMEN; VASOACTIVE AGENT; 8-CHLOROCARBOCHROMEN; ANTITHROMBOCYTIC AGENT; CARBOCROMEN; DRUG DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFICACY; EXTERNAL EAR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TINNITUS; ADOLESCENT; COMPARATIVE STUDY; EVALUATION; HEARING; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AUDITORY PERCEPTION; CHROMONAR; EAR, EXTERNAL; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TINNITUS; TREATMENT OUTCOME;

EID: 0034808439     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Jost C. Un bonne indication de la 6-acetoxy-thimoxy-ethyl-dimethylanine. Le traitement des acouphenes. Vie medicale. Actualite 1964; 1 (30): 31-34.
2. Guerrier J, Guerrier B, Sultama B. Les indications du praxylene dans les troubles vasculaires en ORL. Revue de Medecine 1973; 34: 220-2204.
3. Jacobs P, Martin G.Die Therapie des tinnitus nach Knaltraumatischer Schading. HNO 1978; 26: 104-107.
4. Meyer B. A multicenter study of tinnitus, epidemiology and therapy Ann Otolaryngol Chir Cervicofac 1986; 103: 85-88.
5. Coyas A. The efficacy of trimetazidine in cochleo-vestibtilar disorders of ischemic origin. Ann Otolaryngol Chir Cervicofac 1990; 107(Suppl 1): 82-87.
6. Pech A. A multicenter double blind versus placebo study of trimetazidine in tinnitus. A clinical approach to tinnitus. Ann Otolaryngol Chir Cervicofac 1990; 107(Suppl 1): 66-67.
7. Murai K, Tyler RS, Marker L, Stouffer J. Review of pharmacologic treatment of tinnitus. Am J Otol 1992; 13(5): 454-464.
8. Hester T, Theilman G, Green W, Jones R. Cycladenilate in the management of tinnitus: a randomized placebo-controlled study. Otolaryngol Head Neck Surg 1998; 118: 329-332.
9. Ohsaki K, Ueno M, Zheng H et al. Evaluation of tinnitus patients by peroral multi-drug treatment. Auris Nasus Larynx 1998; 25: 149-154.
10. Pistor M. Exposé sommaire des proprietés nouvelles de la procaïne locale en pathologie humaine. La Presse Medicale 1958; 66(44): 4-6.
11. Bartoletti C.A. Editoriale. Medicina Estetica 1977; 1: 2-3.
12. Crenna P, Mancia M. Aspetti riflessologici della mesoterapia. Giornale di Mesoterpia 1981; 1: 29-40.
13. Blondi G. Considerazioni ed ipotesi sul meccanismo d'azione della mesoterapia. In: Bartoletti CA, Maggiori S, Tomaselli F, eds. Mesoterapia. Roma: Ed. Salus, 1982: 66-68.
14. Crenna P, Mancia M. Aspetti riflessologici della mesoterapia. Giornale di Mesoterapia 1981; 1: 29-40.
15. Maggiori S. Ruolo del farmaco in mesoterapia e suo razionale impiego. In: Bartoletti CA, Maggiori S, Tomaselli F, eds. Mesoterapia. Roma: Ed. Salus, 1982: 30-31.
16. Daaloz-Bourguignon. Lu Mésotherapie. Paris: Ed. Maloine, 1983.
17. Maggiori S, Tomaselli F, Bartoletti CA. L'infiltrazione intradermica. Medicina Estetica 1988; 1: 377-381.
18. Tomaselli F, Caputo M, Cogliano M et al. II microcircolo: correlazioni fisiopatologiche. Approccio farmacologico. Medicina Estetica 1997; 4: 267-273.
19. Fasani U. Mesoterapia-Metodologia e pralica. Milano: Ed. OEMF Intern, 1997.
20. Pistor M. Una sfida terapeutica: la mesoterapia. Roma: Ed. Magma, 1974.
21. Causse J, Causse JR, Wiet R. Tinnitus. First Intern. Workshop Otology Today, 21-24 April 1982, Riva del Garda.
22. Shea J, Emmet J, Orchik D et al. Medical treatment of tinnitus. Ann Otol Laryngol 1981; 90: 601.